 | Up a level |
2020
Groen, Harry J. M., Akerley, Wallace L., Souquet, Pierre Jean, Laack, Eckart, Han, Ji-Youn, Smit, Egbert F., Mansfield, Aaron Scott, Garon, Edward B., Wolf, Juergen, Tan, Daniel Shao-Weng, Heist, Rebecca Suk, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Orlov, Sergey (2020). Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2017
De Castro, Gilberto, Jr., Tan, Daniel Shao-Weng, Crino, Lucio, Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Mcculloch, Tracey and Soria, Jean-Charles (2017). First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S7 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Janne, Pasi, Van den Heuvel, Michel, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Mariani, Gabriella, Poltoratskiy, Artem, Ghiorghiu, Dana, Mckeown, Astrid, Kilgour, Elaine, Angell, Helen, Smith, Paul, Kohlmann, Alexander, Lawrence, David, Bowen, Karin and Vansteenkiste, Johan (2017). Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib plus Docetaxel in KRASm Advanced NSCLC. J. Thorac. Oncol., 12 (1). S. S952 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Janne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey 
ORCID: 0000-0001-6080-8042, Blackhall, Fiona ORCID: 0000-0001-8716-3395, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin and Vansteenkiste, Johan
(2017).
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial.
JAMA-J. Am. Med. Assoc., 317 (18).
S. 1844 - 1854.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 1538-3598
Soria, Jean-Charles, Tan, Daniel S. W., Chiari, Rita, Wu, Yi-Long ORCID: 0000-0002-3611-0258, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut L., Orlov, Sergey ORCID: 0000-0001-6080-8042, Cortinovis, Diego, Yu, Chong-Jen ORCID: 0000-0001-5664-9392, Hochmair, Maximillian, Cortot, Alexis B., Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario G., McCulloch, Tracey, Sen, Paramita, Dugan, Margaret, Pantano, Serafino, Branle, Fabrice, Massacesi, Cristian and de Castro, Gilberto, Jr.
(2017).
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Lancet, 389 (10072).
S. 917 - 930.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Tan, Daniel Shao-Weng, Soria, Jean-Charles, De Castro, Gilberto, Jr., Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Struebbe, Gero, Mcculloch, Tracey and Crino, Lucio (2017). PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S1176 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380